Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$15.73 - $22.91 $474,731 - $691,423
-30,180 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$16.95 - $21.74 $253,894 - $325,643
-14,979 Reduced 33.17%
30,180 $645,000
Q3 2021

Nov 10, 2021

SELL
$22.29 - $28.7 $217,082 - $279,509
-9,739 Reduced 17.74%
45,159 $1.01 Million
Q2 2021

Aug 10, 2021

BUY
$22.32 - $32.07 $34,417 - $49,451
1,542 Added 2.89%
54,898 $1.56 Million
Q1 2021

May 14, 2021

BUY
$22.07 - $26.31 $104,898 - $125,051
4,753 Added 9.78%
53,356 $1.21 Million
Q4 2020

Feb 11, 2021

BUY
$16.76 - $23.74 $341,066 - $483,108
20,350 Added 72.03%
48,603 $1.15 Million
Q3 2020

Nov 12, 2020

BUY
$16.35 - $21.4 $451,505 - $590,961
27,615 Added 4328.37%
28,253 $522,000
Q2 2020

Aug 13, 2020

BUY
$16.34 - $25.24 $10,424 - $16,103
638 New
638 $12,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.08B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.